Efficacy and safety of antiplatelet therapy prior to intravenous thrombolysis in acute ischemic stroke patients

黄银辉; 李明媚; 林友榆; 杨美丽; 许盈盈; 卓识途; 陈振杰; 李隽静; 张碧月; 蔡若蔚

您当前的位置：

首页 >

文章列表页 >

Efficacy and safety of antiplatelet therapy prior to intravenous thrombolysis in acute ischemic stroke patients

更新时间：2026-01-09

- Efficacy and safety of antiplatelet therapy prior to intravenous thrombolysis in acute ischemic stroke patients
- Journal of Army Medical University Vol. 36, Issue 3, Pages: 287-291(2014)
- 作者机构：
- 作者简介：
- 基金信息：
- DOI：
  CLC： R453.9;R743.305;R973.2
- Published：2014
- 稿件说明：
移动端阅览
黄银辉,李明媚,林友榆,杨美丽,许盈盈,卓识途,陈振杰,李隽静,张碧月,蔡若蔚.发病前使用过抗血小板药物对急性缺血性脑卒中患者静脉溶栓疗效的影响[J].陆军军医大学学报(原第三军医大学学报),2014,36(03):287-291.

　Huang Yinhui,Li Mingmei,Lin Youyu,Yang Meili,Xu Yingying,Zuo Shitu,Chen Zhenjie,Li Juanjing,Zhang Biyue,Cai Ruowei.Efficacy and safety of antiplatelet therapy prior to intravenous thrombolysis in acute ischemic stroke patients[J].J Amry Med Univ (J Third Mil Med Univ),2014,36(03):287-291.
黄银辉,李明媚,林友榆,杨美丽,许盈盈,卓识途,陈振杰,李隽静,张碧月,蔡若蔚.发病前使用过抗血小板药物对急性缺血性脑卒中患者静脉溶栓疗效的影响[J].陆军军医大学学报(原第三军医大学学报),2014,36(03):287-291. DOI：

　Huang Yinhui,Li Mingmei,Lin Youyu,Yang Meili,Xu Yingying,Zuo Shitu,Chen Zhenjie,Li Juanjing,Zhang Biyue,Cai Ruowei.Efficacy and safety of antiplatelet therapy prior to intravenous thrombolysis in acute ischemic stroke patients[J].J Amry Med Univ (J Third Mil Med Univ),2014,36(03):287-291. DOI：

摘要

目的探讨发病前使用过抗血小板药物治疗的急性缺血性脑卒中患者静脉溶栓治疗的疗效及安全性。 方法 从2006年4月到2012年11月连续收集发病6 h内静脉溶栓治疗的急性缺血性脑卒中患者作为研究对象。根据发病前有无使用过抗血小板药物治疗将上述患者分为使用过抗血小板药物组和未使用过抗血小板药物组。采用改良的Rankin量表评价神经功能恢复状况。结果 181例患者中发病前使用过抗血小板药物的溶栓治疗组34例，未使用过抗血小板药物的溶栓治疗组147例。两组在90 d内溶栓预后良好率（47.06% vs 57.82%，

=0.255）、颅内出血的发生率（11.76% vs 6.12%，

=0.251）、症状性颅内出血的发生率（8.82% vs 4.08%，

=0.252）及病死率（8.82% vs 4.76%，

=0.350）均无统计学差异。Logistic多因素回归分析显示溶栓前头颅CT有早期缺血改变、溶栓前NIHSS评分是症状性颅内出血的危险因素，溶栓前头颅CT早期缺血改变、溶栓前NIHSS评分、溶栓前血糖、溶栓前收缩压、症状性颅内出血是影响溶栓预后的因素。结论发病前使用过抗血小板药的急性缺血性脑卒中患者静脉溶栓治疗安全、有效。

Abstract

Objective To explore that the efficacy and safety of antiplatelet (AP) therapy prior to intravenous thrombolysis in acute ischemic stroke patients. Methods The patients with acute ischemic stroke who received intravenous therapy within 6 h from symptom onset were included

from April 2006 to November 2012. According to the prior use of AP drugs

a total of 181 patients were divided into AP drugs-treated group (AP group

n=34) and no AP drugs-treated group (no AP

group

n=147). Modified Rankin scale was used to evaluate the recovery of neurological functions. Results There was no significant difference in efficacy (47.06% vs 57.82%

=0.255)

intracranial hemorrhage (11.76% vs 6.12%

P=0.251)

symptomatic intracranial hemorrhage (8.82% vs 4.08%

=0.252) and mortality rate (8.82% vs 4.76%

=0.350) between the two groups. Logistic regression analysis showed that high baseline NIHSS score and early ischemic changes (EICs) on brain CT were related to intracranial hemorrhage independently. No early ischemic changes on brain CT

lower blood glucose level

lower systolic blood pressure level

and lower baseline NIHSS score were related to good outcome independently. Conclusion The prior use of AP drugs in acute ischemic stroke patients with intravenous thrombolysis therapy is safe and effective.

关键词

Keywords

references

Views

下载量

CSCD

Alert me when the article has been cited

提交

Tools

Publicity Resources

Efficacy and safety of HCQ versus spironolactone in treatment of IgA nephropathy based on RAASi: a real-world study

Efficacy and clinical outcomes of different antiviral regimens in HBeAg/HBeAb double-positive patients with chronic hepatitis B

Progress and prospects of neurorehabilitation for patients with prolonged disorders of consciousness

Application of telemedicine consultation system in coordination of regionalization network for diagnosis and treatment of acute ischemic stroke

Efficacy of autologous hematopoietic stem cell transplantation in treatment of relapsed and/or refractory classical Hodgkin lymphoma

Related Author

秦剑

熊加川

赵景宏

安选

刘书宏

夏莉娜

巫贵成

向毅

Related Institution

No data

⁰